title: Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010).
authors.forename: David E
authors.initials: DE
authors.lastname: Kemp
authors.forename: James M
authors.initials: JM
authors.lastname: Eudicone
authors.forename: Robert D
authors.initials: RD
authors.lastname: McQuade
authors.forename: Jessie S
authors.initials: JS
authors.lastname: Chambers
authors.forename: Ross A
authors.initials: RA
authors.lastname: Baker
mesh_terms: D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole